🔗 Share this article

An underground market for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a robust market exists on messaging services, where communities with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors promote the substance there before directing customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.

Some experts stated the demand for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or imprisonment.

Platform Response and Material Elimination

According to TikTok, the service has removed problematic material and banned related keywords and query recommendations. The company stated it was dedicated to keeping the platform safe and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Research also discovered groups with up to nine thousand members marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, positive reviews and step-by-step guides for mixing or administering at residence.

After moments of joining one group, a vendor shared contact information, where most transactions occur. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Inside these groups, messages show dark colored parcels with postal service stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how long a injector should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they can’t verify. Although the research behind this drug is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has already seen individuals injured by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to potentially significant health risks”.